Metabolomics
Recently, most of my research has be directed towards volatile organic compounds and their use as biomarkers of IBS, IBD and various cancers.

The intestinal microbiome and mycobiome
My group also looks at the microbiome and mycobiome of the intestine in humans, mice and equines.

Clinical interests
I have an ongoing-interest in IBD and IBS.